stars 1 stars 2 stars 3

At NeVap, we are on a mission to dramatically reduce Ventilator Associated Pneumonia, the most common, serious, deadly, and expensive hospital acquired infection problem in modern medicine. Through lean physician development and design methods, NeVap is able to rapidly create cost effective solutions that reach patients years before other medical device companies and utilize a fraction of their development costs. Our team of seasoned medical device development and scaling professions have put together a system of development that far exceeds industry standards and allows for significant medical device innovation and quality. Today, we have developed the NeVap Aspire Subglottic Suction Endotracheal Tube, a FDA & CE Mark cleared device that allows for superior Infection protection in the Operating Room, Intensive Care Unit and Emergency Department. If you are an Anesthesiologist, Pulmonologist, Intensivist, Nurse, Trauma Surgeon, ENT, Respiratory Therapist, Manager, Infection Prevention professional, or even a Hospital Executive trying to reduce infections, NeVap devices can offer significant cost savings and clinical benefits.

NeVap Questions

The NeVap annual revenue was $4 million in 2026.

Brenton Hanlon is the CEO of NeVap.

3 people are employed at NeVap.

NeVap is based in San Jose, California.

The NAICS codes for NeVap are [339, 33].

The SIC codes for NeVap are [38, 384].

Top NeVap Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users